GT Biopharma GTBP
NASDAQ GTBP
$6.47 -0.41 (-5.96%)
At close: Sep 30, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Asset Utilization Ratio (2011 - 2016)

Updated

GT Biopharma's Asset Utilization Ratio came in at 0.44 for Q1 2016.

Analysis

GT Biopharma (GTBP) Asset Utilization Ratio (2011 - 2016) Analysis & Trends

For FY2015, GT Biopharma's Asset Utilization Ratio was 0.06, down 51.4% from FY2014.

  • Going back by year, Asset Utilization Ratio was 0.12 in FY2014, 1.93 in FY2012 and 0.17 in FY2011.
  • The Q1 2016 figure represents the highest quarterly Asset Utilization Ratio since Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 GT Biopharma 9.11 Mn 9.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 0.44
Mar 31, 2014 3.42
Mar 31, 2013 2.49
Dec 31, 2012 2.17
Sep 30, 2012 1.17
Jun 30, 2012 0.05
Mar 31, 2012 0.05
Dec 31, 2011 0.10
Sep 30, 2011 0.11
API Access

GT Biopharma Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GTBP&period=max&api_key=YOUR_API_KEY